blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1373234

EP1373234 - UROKINASE INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.12.2008
Database last updated on 15.06.2024
Most recent event   Tooltip22.10.2010Lapse of the patent in a contracting state
New state(s): GR		published on 24.11.2010  [2010/47]
Applicant(s)For all designated states
Wilex AG
Grillparzerstrasse 16
81675 München / DE
[2006/01]
Former [2004/01]For all designated states
Pentapharm AG
Engelgasse 109
4052 Basel / CH
Inventor(s)01 / ZIEGLER, Hugo
Im Bohnacker 15
CH-4108 Witterswil / CH
 [2004/01]
Representative(s)Weiss, Wolfgang
Weickmann & Weickmann
Patent- und Rechtsanwälte PartmbB
Postfach 860 820
81635 München / DE
[N/P]
Former [2005/48]Weiss, Wolfgang
Weickmann & Weickmann Patentanwälte Postfach 86 08 20
81635 München / DE
Former [2005/43](deleted)
Former [2004/01]Braun, André, et al
BRAUN & PARTNER, Reussstrasse 22
4054 Basel / CH
Application number, filing date02703436.219.03.2002
[2004/01]
WO2002CH00162
Priority number, dateWO2001CH0017821.03.2001         Original published format: PCT/CH01/00178
[2004/01]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO02074756
Date:26.09.2002
Language:DE
[2002/39]
Type: A2 Application without search report 
No.:EP1373234
Date:02.01.2004
Language:DE
The application published by WIPO in one of the EPO official languages on 26.09.2002 takes the place of the publication of the European patent application.
[2004/01]
Type: B1 Patent specification 
No.:EP1373234
Date:13.02.2008
Language:DE
[2008/07]
Search report(s)International search report - published on:EP12.12.2002
ClassificationIPC:C07D295/20, A61K31/495, A61P35/00
[2004/01]
CPC:
C07D295/215 (EP,US); A61K31/495 (EP,US); A61P17/00 (EP);
A61P35/00 (EP); A61P35/04 (EP); A61P43/00 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/01]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:UROKINASE-INHIBITOREN[2004/01]
English:UROKINASE INHIBITORS[2004/01]
French:INHIBITEURS D'UROKINASE[2004/01]
Entry into regional phase21.10.2003National basic fee paid 
21.10.2003Designation fee(s) paid 
21.10.2003Examination fee paid 
Examination procedure28.10.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
21.10.2003Examination requested  [2004/01]
31.07.2007Communication of intention to grant the patent
05.11.2007Fee for grant paid
05.11.2007Fee for publishing/printing paid
Opposition(s)14.11.2008No opposition filed within time limit [2009/04]
Fees paidRenewal fee
23.03.2004Renewal fee patent year 03
17.03.2005Renewal fee patent year 04
30.12.2005Renewal fee patent year 05
29.12.2006Renewal fee patent year 06
31.12.2007Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY13.02.2008
DK13.02.2008
FI13.02.2008
IE13.02.2008
IT13.02.2008
NL13.02.2008
TR13.02.2008
AT19.03.2008
LU19.03.2008
BE31.03.2008
CH31.03.2008
LI31.03.2008
MC31.03.2008
GB13.05.2008
SE13.05.2008
GR14.05.2008
ES24.05.2008
PT14.07.2008
[2010/47]
Former [2010/37]CY13.02.2008
DK13.02.2008
FI13.02.2008
IE13.02.2008
IT13.02.2008
NL13.02.2008
TR13.02.2008
AT19.03.2008
LU19.03.2008
BE31.03.2008
CH31.03.2008
LI31.03.2008
MC31.03.2008
GB13.05.2008
SE13.05.2008
ES24.05.2008
PT14.07.2008
Former [2010/32]CY13.02.2008
DK13.02.2008
FI13.02.2008
IE13.02.2008
IT13.02.2008
NL13.02.2008
AT19.03.2008
LU19.03.2008
BE31.03.2008
CH31.03.2008
LI31.03.2008
MC31.03.2008
GB13.05.2008
SE13.05.2008
ES24.05.2008
PT14.07.2008
Former [2009/39]CY13.02.2008
DK13.02.2008
FI13.02.2008
IE13.02.2008
IT13.02.2008
NL13.02.2008
AT19.03.2008
BE31.03.2008
CH31.03.2008
LI31.03.2008
MC31.03.2008
GB13.05.2008
SE13.05.2008
ES24.05.2008
PT14.07.2008
Former [2009/33]CY13.02.2008
DK13.02.2008
FI13.02.2008
IE13.02.2008
NL13.02.2008
BE31.03.2008
CH31.03.2008
LI31.03.2008
MC31.03.2008
GB13.05.2008
SE13.05.2008
ES24.05.2008
PT14.07.2008
Former [2009/29]DK13.02.2008
FI13.02.2008
IE13.02.2008
NL13.02.2008
BE31.03.2008
CH31.03.2008
LI31.03.2008
MC31.03.2008
GB13.05.2008
SE13.05.2008
ES24.05.2008
PT14.07.2008
Former [2009/12]DK13.02.2008
FI13.02.2008
IE13.02.2008
NL13.02.2008
BE31.03.2008
CH31.03.2008
LI31.03.2008
MC31.03.2008
SE13.05.2008
ES24.05.2008
PT14.07.2008
Former [2008/49]DK13.02.2008
FI13.02.2008
IE13.02.2008
NL13.02.2008
MC31.03.2008
SE13.05.2008
ES24.05.2008
PT14.07.2008
Former [2008/48]DK13.02.2008
FI13.02.2008
IE13.02.2008
NL13.02.2008
MC31.03.2008
SE13.05.2008
ES24.05.2008
Former [2008/46]DK13.02.2008
FI13.02.2008
MC31.03.2008
SE13.05.2008
ES24.05.2008
Former [2008/39]FI13.02.2008
ES24.05.2008
Former [2008/35]ES24.05.2008
Cited inInternational search[A]WO9605189  (PENTAPHARM AG [CH], et al) [A] 1-21 * page 3, line 6 - page 5, paragraph 3 *;
 [A]WO0017158  (PENTAPHARM AG [CH], et al) [A] 1-21 * claim 1 *;
 [PX]  - A ZEGA ET AL, "Novel Thromibn inhibitors with azaphenylalanine scaffold", PHARMAZIE., VEB VERLAG VOLK UND GESUNDHEIT. BERLIN., DD, (20010901), vol. 56, ISSN 0031-7144, pages 683 - 685, XP002215735 [PX] 1-21 * the whole document *
 [A]  - SANGSOO K ET AL, "Rational design of selective thrombin inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (19970408), vol. 7, no. 7, ISSN 0960-894X, pages 769 - 774, XP004136127 [A] 1-21 * figures 2,3 *

DOI:   http://dx.doi.org/10.1016/S0960-894X(97)00115-7
 [A]  - YEONG S O ET AL, "Discovery of LB30057, a benzamidrazone-based selective oral thrombin inhibitor", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (19980317), vol. 8, no. 6, ISSN 0960-894X, pages 631 - 634, XP004136935 [A] 1-21 * figure 1 *

DOI:   http://dx.doi.org/10.1016/S0960-894X(98)00079-1
 [A]  - ZEGA A ET AL, "Design and structure-activity relationship of thrombin inhibitors with an azaphenylalanine scaffold: potency and selectivity enhancements via P2 optimization", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER SCIENCE LTD, GB, (2001), no. 9, ISSN 0968-0896, pages 2745 - 2756, XP002196794 [A] 1-21 * figure 1 *

DOI:   http://dx.doi.org/10.1016/S0968-0896(01)00202-4
 [A]  - JÖRG STÜRZEBECHER ET AL, "Synthesis and Structure-Activity Relationships of Potent Thrombin Inhibitors: Piperazides of Amidinophenylalanine", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (19970912), vol. 19, no. 40, ISSN 0022-2623, pages 3091 - 3099, XP002077904 [A] 1-21 * tables 1-3 *
 [A]  - STURZEBECHER J ET AL, "3-Amidinophenylalanine-based Inhibitors of Urokinase", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (19991101), vol. 9, no. 21, ISSN 0960-894X, pages 3147 - 3152, XP004181024 [A] 1-21 * table 1 *

DOI:   http://dx.doi.org/10.1016/S0960-894X(99)00541-7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.